UPC grants ‘in absentia’ permanent injunction on agricultural tool

​
July 21, 2025

Maschio Gaspardo S.p.A. v Spiridonakis Bros GP (UPC_CFI_513/2024 relating to EP1998604)

Order of 25 June 2025 (ORD_17812/2025 [1])

This Decision from the Central Division of the Unified Patent Court in Milan relates to EP1998604 (EP ‘604). The Applicant, Maschio Gaspardo S.p.A. ("MG"), requested a permanent injunction by Article 63(1) UPCA against Spiridonakis Bros GP ("Spiridonakis"), to prevent the sale and distribution of Spiridonakis' ‘Bellota tool'.

Spiridonakis did not file an infringement defence, and the Court granted the requested permanent injunction, ordering Spiridonakis to refrain from any further acts of infringement, to provide MG with any information regarding the origin and the distribution channels of the infringing products, and to bear the legal costs of the proceedings and other expenses incurred by MG.

Decision ‘in absentia'

MG filed an action for patent infringement against Spiridonakis on 5 September 2024 with the Central Divisionin Milan. The alleged infringement relates to the sale and distribution of an agricultural tool by the Defendant under the name of ‘Bellota tool'. The ‘Bellota tool' allegedly infringed EP1998604, validated in France, Turkey, Italy, Germany, Romania, Czech Republic and Bulgaria.

MG requested a decision by default under R. 355(1) RoP, based on Spiridonakis failing to file written submissions within the relevant time limit and failing to appear at the oral hearing. MG requested grant of a permanent injunction by Article 63(1) UPC in the contracting member states where EP ‘604 is valid.

The Court stated that a default decision against a Defendant is subject to:

  • verification of proper service;
  • the absence of preliminary grounds for inadmissibility of the claim; and
  • the assessment that the facts put forward by the claimant justify the remedy sought (Rule 355.2).

The Court stated that it was apparent from the service notification that the statement of claim was validly served on Spiridonakis on January 2, 2025.

The Court also stated that Rule 355.2 imposes de minimis factual allegations for a decision to be issued in absentia, namely those set out in Rules 12 and 13 RoP. That is, reasonably providing the Court with the patent documentation, as well as all documents and evidence related to infringement and damages, if requested.

Furthermore, the Court found that bringing the action before the Central Division was justified since:

  • the principal place of residence and place of business of Spiridonakis is Greece, which is outside the territory of the Contracting Member States (Article 33(1) UPCA, paragraph 3); and
  • Bulgaria, as a UPCA Contracting member state, does not host a local division and does not participate in a regional division (Article 33(1) UPCA, paragraph 4). Bulgaria was the place where the specific infringing acts were alleged to have occurred.

Validity

The Court did not find it was necessary to take a stand on patent invalidity, since this is not an issue that is raised by the Court ex officio, even in the case of a decision by default. According to the case law of the European Court of Justice (Case C-44/21), granted European patents enjoy a presumption of validity from the date of publication of their grant (cf. LD Munich, UPC_CFI_508/2023, 9 January 2025, air up v Guangzhou Aiyun).

Accordingly, EP ‘604 was presumed to be valid by the Court.

Infringement

EP ‘604 relates to a ‘reversible tool for agricultural subsoilers'. This is a tool that can be mounted on agricultural machinery to penetrate and break up compacted soil layers below the surface.

MG conducted two online purchases (on 19 July 2024 and 6 August 2024) through Spiridonakis' website for delivery of the allegedly infringing ‘Bellota tool' in Bulgaria. These products were labelled in the shipment receipts as "Spare parts nail riper nail Maschio" and "Spare parts for agricultural machinery", according to automatic translations to English.

MG's CTO inspected the accused products and submitted (together with photographic evidence) that they were almost identical in shape, dimensions, and features to the patented embodiment. A panel of judges of the Milan Central Division travelled to Cremona to visually assess the structure and operation of the original product sold by MG and the allegedly infringing product sold by Spiridonakis.

Moreover, it was noted by MG that the ‘Bellota tool' on the website of Spiridonakis.com was marketed as a "Point Riper Maschio Bellota" tool, thereby evoking the name of the patent owner, Maschio Gaspardo, with the purpose of confusing the customer about the origin of the product. It was also submitted that the ‘Bellota tool' also showed the product code R17622960, which is the distinguishing code of MG's product.

MG stated that Spiridonakis is offering and placing on the market products having all the features of at least claims 1, 2, 3, 5, 6, 9, and 10 of patent EP ‘604, at least in Bulgaria, where EP ‘604 is valid. The Court decided that the statement of claim was sufficiently detailed and supported by consistent evidence, in line with the requirements of Rule 355.2.

The Court decided that that the infringing offer, sale and distribution of the ‘Bellota tool' in Bulgaria was proven. While the Court primarily saw this as an act of primary infringement (Art. 25 UPCA), in the alternative the Court held that the requirements for indirect infringement (Art. 26 UPCA) with regard to double territoriality were met, since the attacked embodiment could be supplied at least in Bulgaria, where EP ‘604 is valid, and the ‘Bellota tool' is shipped.

Order to Communicate Information

It was further submitted that that the allegedly infringing product bears the trademark of the company Bellota, suggesting that Spiridonakis' allegedly infringing product is manufactured by the company Bellota. MG stated that they have a legitimate interest in understanding where the production takes place and who might be the infringing company, therefore justifying requesting the Court to order Spiridonakis to communicate, by Article 67(1) UPCA, information concerning the origin and distribution channels of the infringing products.

Decision

The Court found that the request from MG of ordering Spiridonakis to bear the legal costs of € 25,000 was well-founded under RoP 152, considering that the costs requested (€ 15,000 euro for the preparation of the case and € 10,000 euro for the oral hearing) were well below the minimum level of recoverable costs set out by the Presidium for an infringement action and appeared to be in line with the activity done by the legal representatives.

Accordingly, the Court granted the permanent injunction and ordered Spiridonakis refrain from any acts of infringement within UPC member states, and the payment of € 25,000 for legal costs and to refund the court fees paid by MG.

The Court also ordered Spiridonakis to communicate to MG information regarding the origin and the distribution channels of the infringing products, the quantities produced, delivered, ordered, the price related to the sales and the identity of any person involved in the production of the ‘Bellota tool'.

[1] https://www.unified-patent-court.org/en/node/136198

The Latest Thought Leadership pieces in the Content Hub

Applying Ocado, the UPC grants a R262 request to access CFI documents
July 9, 2025
NJOY Netherlands B.V v Juul Labs International, Inc (UPC_CFI_309/2023) Order issued 9 June 2025 (ORD_27305/2025) [1] The Paris Central Division revoked Juul Lab's patent EP 3 498 115 B1 by decision...
Stay in the Know

The Patent Strategist

Get expert insights and the top patent stories delivered straight to your inbox.

Heading
This is some text inside of a div block.
This is some text inside of a div block.

Latest Insights

Showing 0 of 100
What are the options if you want to be able to use the UPC?
03 November 2022
All unitary patents fall within the competence of the Unified Patent Court (UPC). Additionally, classical validations of European Patents in states which have ratified the UPC agreement are within...
#
Patenting
​
What is the Unified Patent Court?
01 November 2022
The Unified Patent Court ("UPC") is a new pan-European court which opened for business on 1 June 2023. It adjudicates disputes relating to the new Unitary Patents and also to existing and future...
#
Litigation
​
What is the Unitary Patent and how do I get one?
01 November 2022
The Unitary Patent (UP) is a single patent right, obtained via the European Patent Office, covering all EU Member States which have ratified the agreement at the patent grant date, and is subject to...
#
Patenting
​
How does the opt-out work?
01 November 2022
The Unified Patent Court (UPC) will ultimately be responsible for all litigation in participating member states relating to patents granted by the European Patent Office (EPO); national courts in...
#
Patenting
​
What languages does the UPC use?
01 November 2022
Central Division Proceedings at the central division are in the language in which the patent was granted (i.e., either French, German or English).
#
Patenting
​
IP considerations arising from increased micro mobility competition
24 June 2022
Following the Queen's Speech, and years of consultations and lobbying from the micro mobility sector, it looks like the e-scooter industry is in for a bumper year.
#
Patenting
​
Are open-source patent portfolios the key to the EV revolution?
16 June 2022
The widespread rollout of electric vehicles is viewed as a crucial part of the UK's green revolution. When discussing how this can be achieved, charging infrastructure is often cited as the key to...
#
Patenting
​
What is the likely timing of the UPC and UP coming into being?
09 June 2022
The Unified Patent Court (UPC) is currently completing preparations to be open for business (under the Protocol on the Provisional Application of the UPC Agreement (the ‘PAP-Protocol')).
#
Litigation
​
The Unitary Patent System is on the way
20 January 2022
We reported last year that the Unitary Patent and Unified Patent Court (UPC) were progressing. The main hurdle left to clear was sufficient countries ratifying the Protocol on the Provisional...
#
Litigation
​
Hybrid event: Healthcare Innovation & Strategy Series - IP Strategy Beyond Drafting Patents
19 October 2021
We would like to invite you to join us for the second part of our life science and medtech event on 09 November where we will continue to explore upcoming trends in IP and healthcare.
#
Patenting
​
Unlocking healthcare with AI
16 September 2021
Much has been written about the development of artificial intelligence (AI) and its potential to reshape everyday life.This potential is already being realised in healthcare, with health...
#
Patenting
​
License to heal
07 September 2021
The hallmark of 5G is extremely low latency speeds. In theory, robotics could be controlled from long distances with just 0.1 seconds of a delay.
#
Patenting
​
Ask the Experts: What can I do if someone is using my invention without my permission?
02 September 2021
In the previous articles, we looked at the mechanics of filing a patent application. In this last article of our ‘Ask the Experts' series, we will be addressing some of the other ways in which a...
#
Patenting
​
The personalised healthcare boom
01 September 2021
Personalised healthcare is a fairly new term relating to technology that gives individuals effective healthcare based on their own unique attributes.
#
Patenting
​
Ask the Experts: How can I manage the costs of a patent?
24 August 2021
In previous articles, we addressed the questions of whether applying for a patent is appropriate, and if so, when this should be done. This article addresses questions around the process for filing a...
#
Patenting
​